Patrick James Orme

Array ( [id] => 5398475 [patent_doc_number] => 20090318538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'POLYMERIC OLIGONUCLEOTIDE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/544753 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12988 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318538.pdf [firstpage_image] =>[orig_patent_app_number] => 12544753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442346 [patent_doc_number] => 07928084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Regulation of integrin surface expression' [patent_app_type] => utility [patent_app_number] => 12/543836 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 14601 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928084.pdf [firstpage_image] =>[orig_patent_app_number] => 12543836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378666 [patent_doc_number] => 20100081710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Modified L-Nucleic Acid' [patent_app_type] => utility [patent_app_number] => 12/541142 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15006 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081710.pdf [firstpage_image] =>[orig_patent_app_number] => 12541142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967165 [patent_doc_number] => 07939654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Platelet derived growth factor (PDGF) nucleic acid ligand complexes' [patent_app_type] => utility [patent_app_number] => 12/512780 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 30 [patent_no_of_words] => 28357 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939654.pdf [firstpage_image] =>[orig_patent_app_number] => 12512780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375810 [patent_doc_number] => 20100076056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'MODIFIED iRNA AGENTS' [patent_app_type] => utility [patent_app_number] => 12/510050 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 64218 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076056.pdf [firstpage_image] =>[orig_patent_app_number] => 12510050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028299 [patent_doc_number] => 08143231 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-03-27 [patent_title] => 'Method of reducing HIV-replication in human body tissue' [patent_app_type] => utility [patent_app_number] => 12/460576 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 5188 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143231.pdf [firstpage_image] =>[orig_patent_app_number] => 12460576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440912 [patent_doc_number] => 08710022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Cell proliferation inhibitor' [patent_app_type] => utility [patent_app_number] => 13/054288 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21603 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6114294 [patent_doc_number] => 20110190483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Stimulus-Responsive Apta Chelamers' [patent_app_type] => utility [patent_app_number] => 13/003047 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190483.pdf [firstpage_image] =>[orig_patent_app_number] => 13003047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451033 [patent_doc_number] => 07964356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Method for generating aptamers with improved off-rates' [patent_app_type] => utility [patent_app_number] => 12/499967 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 28 [patent_no_of_words] => 33262 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964356.pdf [firstpage_image] =>[orig_patent_app_number] => 12499967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7796046 [patent_doc_number] => 08124753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene' [patent_app_type] => utility [patent_app_number] => 12/493901 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7651 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124753.pdf [firstpage_image] =>[orig_patent_app_number] => 12493901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543794 [patent_doc_number] => 20100016215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY' [patent_app_type] => utility [patent_app_number] => 12/493140 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 14899 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016215.pdf [firstpage_image] =>[orig_patent_app_number] => 12493140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997607 [patent_doc_number] => 08080651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/456667 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 18849 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080651.pdf [firstpage_image] =>[orig_patent_app_number] => 12456667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510159 [patent_doc_number] => 20110256217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'PULSATILE RELEASE COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL DRUG ABSORPTION' [patent_app_type] => utility [patent_app_number] => 12/485675 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20396 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256217.pdf [firstpage_image] =>[orig_patent_app_number] => 12485675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937705 [patent_doc_number] => 20110213009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA' [patent_app_type] => utility [patent_app_number] => 12/991329 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5833 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213009.pdf [firstpage_image] =>[orig_patent_app_number] => 12991329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6145272 [patent_doc_number] => 20110130557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'INTERCALATING TRIPLEXES AND DUPLEXES USING ARYL NAPHTHOIMIDAZOL AND PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/991058 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13777 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130557.pdf [firstpage_image] =>[orig_patent_app_number] => 12991058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140485 [patent_doc_number] => 08580946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Multi-conjugate of siRNA and preparing method thereof' [patent_app_type] => utility [patent_app_number] => 12/514306 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12514306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982067 [patent_doc_number] => 08513181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Substances and compositions for enhancing DNA repair and methods of use' [patent_app_type] => utility [patent_app_number] => 12/990373 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 17864 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629909 [patent_doc_number] => 08361981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides' [patent_app_type] => utility [patent_app_number] => 12/431997 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12431997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982067 [patent_doc_number] => 08513181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Substances and compositions for enhancing DNA repair and methods of use' [patent_app_type] => utility [patent_app_number] => 12/990373 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 17864 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515573 [patent_doc_number] => 20090215880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Composition and Method for IN VIVO and IN VITRO Attenuation of Gene Expression Using Double Stranded RNA' [patent_app_type] => utility [patent_app_number] => 12/422640 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12745 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215880.pdf [firstpage_image] =>[orig_patent_app_number] => 12422640 [rel_patent_id] =>[rel_patent_doc_number] =>)